1606 Corp. Files 8-K Report
Ticker: CBDW · Form: 8-K · Filed: Sep 17, 2024 · CIK: 1877461
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
1606 Corp. filed an 8-K, likely a routine disclosure.
AI Summary
On September 17, 2024, 1606 Corp. filed an 8-K report. The filing primarily serves as a notification of information and exhibits, without detailing specific financial transactions or material events.
Why It Matters
This 8-K filing indicates that 1606 Corp. is making a regulatory disclosure, which could precede or follow other significant corporate actions.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report without immediate indication of significant financial changes or negative events.
Key Players & Entities
- 1606 Corp. (company) — Registrant
- September 17, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of Incorporation
- 000-56467 (identifier) — Commission File Number
- 86-1497346 (identifier) — I.R.S. Employer Identification Number
- 2425 E. Camelback Rd Suite 150 Phoenix , AZ 85016 (address) — Principal executive offices
- 602-481-1544 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for 1606 Corp.?
The primary purpose of this 8-K filing is to report information and exhibits as required by the SEC, specifically noting 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 17, 2024.
In which U.S. state is 1606 Corp. incorporated?
1606 Corp. is incorporated in Nevada.
What is the business address of 1606 Corp.?
The business address of 1606 Corp. is 2425 E. Camelback Rd Suite 150, Phoenix, AZ 85016.
What is the Commission File Number for 1606 Corp.?
The Commission File Number for 1606 Corp. is 000-56467.
Filing Stats: 633 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2024-09-17 08:00:21
Filing Documents
- cbdw_8k.htm (8-K) — 26KB
- cbdw_ex991.htm (EX-99.1) — 11KB
- 0001477932-24-005773.txt ( ) — 156KB
- cbdw-20240917.xsd (EX-101.SCH) — 6KB
- cbdw-20240917_lab.xml (EX-101.LAB) — 13KB
- cbdw-20240917_cal.xml (EX-101.CAL) — 1KB
- cbdw-20240917_pre.xml (EX-101.PRE) — 8KB
- cbdw-20240917_def.xml (EX-101.DEF) — 2KB
- cbdw_8k_htm.xml (XML) — 4KB
01
Item 7.01. Regulation FD Disclosure. On September 17, 2024, 1606 Corp., a Nevada corporation (the " Company "), filed a press release which announced an LOI entered into with Adnexus Biotechnologies Inc.. The furnishing of the press release is not an admission as to the materiality of any information therein. The information contained in the press release is summary information that is intended to be considered in the context of more complete information included in the Company's filings with the U.S. Securities and Exchange Commission (the " SEC ") and other public announcements that the Company has made and may make from time to time by press release or otherwise. The Company undertakes no duty or obligation to update or revise the information contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures. The information in this Item 7.01 of this Current Report on Form 8-K and the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the press release shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. 2
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated September 17, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 3
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 1606 Corp. Date: September 17, 2024 By: /s/ Austen Lambrecht Austen Lambrecht, Chief Executive Officer 4